Global Circular RNA Synthesis Service Market Growth (Status and Outlook) 2026-2032
The global Circular RNA Synthesis Service market size is predicted to grow from US$ 45.00 million in 2025 to US$ 239 million in 2032; it is expected to grow at a CAGR of 26.8% from 2026 to 2032.
Circular RNA synthesis services provide integrated technical support for the design, production, purification, and quality control of customized circular RNA molecules based on customer-defined or jointly optimized target sequences. The typical service workflow includes circular RNA sequence design, DNA template construction, in vitro transcription, RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circular RNA samples, preclinical drug substance, process-development packages, and GMP clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials, while downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutions, and hospital research centers. The overall industry gross margin typically around 40%?60%.
The circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although demand is shifting from basic sample preparation toward sequence optimization, circularization process development, impurity control, analytical method establishment, and clinical manufacturing. The early market was primarily served by life-science tools and gene-synthesis companies supplying microgram- to milligram-scale customized samples. As circular RNA drugs, vaccines, and in vivo cell therapy programs advance, several integrated RNA service providers are developing gram-scale production, lipid nanoparticle formulation, and GMP-compliant manufacturing capabilities. Global supply is currently concentrated in China and the United States. Chinese providers have established broad capabilities in research services, sequence analysis, circularization process development, and integrated CRDMO support, while U.S.-based providers generally benefit from broader international customer coverage and established nucleic acid manufacturing infrastructure.
Future competition will shift from demonstrating basic circularization capability toward reliably delivering high-purity, translatable, low-immunogenicity products that meet regulatory requirements. Competitive differentiation will increasingly depend on scarless circularization, long-sequence compatibility, process robustness across different payloads, removal of double-stranded RNA and linear precursors, batch reproducibility, and biological potency testing. Research-grade projects will continue to account for a large number of orders, but most value growth is expected to come from preclinical process development, GMP manufacturing, analytical validation, and LNP formulation. Suppliers with integrated capabilities covering sequence design, template preparation, circularization, purification, analytics, and formulation will be better positioned to retain projects as they progress toward clinical development.
Market growth is being driven by the expanding development of circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo CAR-T, and other gene and cell therapy applications. Compared with building an internal small-scale production platform, outsourcing to specialized providers gives developers access to validated circularization elements, process expertise, analytical methods, and scale-up equipment, helping reduce development risk and shorten timelines to animal studies and regulatory submissions. As projects move from discovery into preclinical and clinical stages, additional testing for purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency increases the value of individual service contracts. Continued interest from large pharmaceutical companies in next-generation RNA technologies may also support greater demand for platform collaboration and outsourced manufacturing.
The main barriers are the lack of harmonized technical standards and differences in how suppliers measure circularization rate, purity, integrity, and expression activity, which make direct service comparison difficult. Conventional PIE methods may introduce residual sequences, sequence restrictions, and unwanted by-products, while ligase-based methods face challenges related to enzyme cost, terminal design, and scale-up. Circularization efficiency, purification recovery, and batch consistency for long RNA sequences still require improvement. Clinical-grade production also requires more stringent raw-material controls, validated analytical methods, and quality standards. In addition, the limited number of clinical-stage downstream programs results in low GMP capacity utilization, exposing suppliers to high capital requirements, uneven order flow, and project cancellation risks.
LPI (LP Information)' newest research report, the ?Circular RNA Synthesis Service Industry Forecast? looks at past sales and reviews total world Circular RNA Synthesis Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Circular RNA Synthesis Service sales for 2026 through 2032. With Circular RNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular RNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global Circular RNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circular RNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Circular RNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular RNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular RNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Circular RNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Circular RNA synthesis services provide integrated technical support for the design, production, purification, and quality control of customized circular RNA molecules based on customer-defined or jointly optimized target sequences. The typical service workflow includes circular RNA sequence design, DNA template construction, in vitro transcription, RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circular RNA samples, preclinical drug substance, process-development packages, and GMP clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials, while downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutions, and hospital research centers. The overall industry gross margin typically around 40%?60%.
The circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although demand is shifting from basic sample preparation toward sequence optimization, circularization process development, impurity control, analytical method establishment, and clinical manufacturing. The early market was primarily served by life-science tools and gene-synthesis companies supplying microgram- to milligram-scale customized samples. As circular RNA drugs, vaccines, and in vivo cell therapy programs advance, several integrated RNA service providers are developing gram-scale production, lipid nanoparticle formulation, and GMP-compliant manufacturing capabilities. Global supply is currently concentrated in China and the United States. Chinese providers have established broad capabilities in research services, sequence analysis, circularization process development, and integrated CRDMO support, while U.S.-based providers generally benefit from broader international customer coverage and established nucleic acid manufacturing infrastructure.
Future competition will shift from demonstrating basic circularization capability toward reliably delivering high-purity, translatable, low-immunogenicity products that meet regulatory requirements. Competitive differentiation will increasingly depend on scarless circularization, long-sequence compatibility, process robustness across different payloads, removal of double-stranded RNA and linear precursors, batch reproducibility, and biological potency testing. Research-grade projects will continue to account for a large number of orders, but most value growth is expected to come from preclinical process development, GMP manufacturing, analytical validation, and LNP formulation. Suppliers with integrated capabilities covering sequence design, template preparation, circularization, purification, analytics, and formulation will be better positioned to retain projects as they progress toward clinical development.
Market growth is being driven by the expanding development of circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo CAR-T, and other gene and cell therapy applications. Compared with building an internal small-scale production platform, outsourcing to specialized providers gives developers access to validated circularization elements, process expertise, analytical methods, and scale-up equipment, helping reduce development risk and shorten timelines to animal studies and regulatory submissions. As projects move from discovery into preclinical and clinical stages, additional testing for purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency increases the value of individual service contracts. Continued interest from large pharmaceutical companies in next-generation RNA technologies may also support greater demand for platform collaboration and outsourced manufacturing.
The main barriers are the lack of harmonized technical standards and differences in how suppliers measure circularization rate, purity, integrity, and expression activity, which make direct service comparison difficult. Conventional PIE methods may introduce residual sequences, sequence restrictions, and unwanted by-products, while ligase-based methods face challenges related to enzyme cost, terminal design, and scale-up. Circularization efficiency, purification recovery, and batch consistency for long RNA sequences still require improvement. Clinical-grade production also requires more stringent raw-material controls, validated analytical methods, and quality standards. In addition, the limited number of clinical-stage downstream programs results in low GMP capacity utilization, exposing suppliers to high capital requirements, uneven order flow, and project cancellation risks.
LPI (LP Information)' newest research report, the ?Circular RNA Synthesis Service Industry Forecast? looks at past sales and reviews total world Circular RNA Synthesis Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Circular RNA Synthesis Service sales for 2026 through 2032. With Circular RNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular RNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global Circular RNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circular RNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Circular RNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular RNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular RNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Circular RNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Custom Synthesis
- Process Development
- Analytical and QC Services
- Other
- PIE Circularization
- Enzymatic Ligation
- Other
- Naked circRNA
- circRNA-LNP
- Other
- Pharmaceutical and Biotechnology Companies
- CRO and CDMO Companies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GenScript Biotech Corporation
- VectorBuilder
- Guangzhou Geneseed Biotech
- uBriGene Biosciences
- Yaohai Bio-Pharma
- Creative Biogene
- Creative Biolabs
- BOC Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circular RNA Synthesis Service Market Size (2021-2032)
2.1.2 Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Circular RNA Synthesis Service by Country/Region (2021, 2025 & 2032)
2.2 Circular RNA Synthesis Service Segment by Type
2.2.1 Custom Synthesis
2.2.2 Process Development
2.2.3 Analytical and QC Services
2.2.4 Other
2.2.5 Circular RNA Synthesis Service Market Size by Type
2.2.5.1 Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
2.3 Circular RNA Synthesis Service Segment by Circularization Method
2.3.1 PIE Circularization
2.3.2 Enzymatic Ligation
2.3.3 Other
2.3.4 Circular RNA Synthesis Service Market Size by Circularization Method
2.3.4.1 Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
2.4 Circular RNA Synthesis Service Segment by Product Format
2.4.1 Naked circRNA
2.4.2 circRNA-LNP
2.4.3 Other
2.4.4 Circular RNA Synthesis Service Market Size by Product Format
2.4.4.1 Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032)
2.4.4.2 Global Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
2.5 Circular RNA Synthesis Service Segment by Application
2.5.1 Pharmaceutical and Biotechnology Companies
2.5.2 CRO and CDMO Companies
2.5.3 Other
2.5.4 Circular RNA Synthesis Service Market Size by Application
2.5.4.1 Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
3 CIRCULAR RNA SYNTHESIS SERVICE MARKET SIZE BY PLAYER
3.1 Circular RNA Synthesis Service Market Size Market Share by Player
3.1.1 Global Circular RNA Synthesis Service Revenue by Player (2021-2026)
3.1.2 Global Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
3.2 Global Circular RNA Synthesis Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULAR RNA SYNTHESIS SERVICE BY REGION
4.1 Circular RNA Synthesis Service Market Size by Region (2021-2026)
4.2 Global Circular RNA Synthesis Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.4 APAC Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.5 Europe Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Circular RNA Synthesis Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Circular RNA Synthesis Service Market Size by Country (2021-2026)
5.2 Americas Circular RNA Synthesis Service Market Size by Type (2021-2026)
5.3 Americas Circular RNA Synthesis Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circular RNA Synthesis Service Market Size by Region (2021-2026)
6.2 APAC Circular RNA Synthesis Service Market Size by Type (2021-2026)
6.3 APAC Circular RNA Synthesis Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circular RNA Synthesis Service Market Size by Country (2021-2026)
7.2 Europe Circular RNA Synthesis Service Market Size by Type (2021-2026)
7.3 Europe Circular RNA Synthesis Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circular RNA Synthesis Service by Region (2021-2026)
8.2 Middle East & Africa Circular RNA Synthesis Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Circular RNA Synthesis Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULAR RNA SYNTHESIS SERVICE MARKET FORECAST
10.1 Global Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.1 Global Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.2 Americas Circular RNA Synthesis Service Forecast
10.1.3 APAC Circular RNA Synthesis Service Forecast
10.1.4 Europe Circular RNA Synthesis Service Forecast
10.1.5 Middle East & Africa Circular RNA Synthesis Service Forecast
10.2 Americas Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.2.1 United States Market Circular RNA Synthesis Service Forecast
10.2.2 Canada Market Circular RNA Synthesis Service Forecast
10.2.3 Mexico Market Circular RNA Synthesis Service Forecast
10.2.4 Brazil Market Circular RNA Synthesis Service Forecast
10.3 APAC Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.3.1 China Circular RNA Synthesis Service Market Forecast
10.3.2 Japan Market Circular RNA Synthesis Service Forecast
10.3.3 Korea Market Circular RNA Synthesis Service Forecast
10.3.4 Southeast Asia Market Circular RNA Synthesis Service Forecast
10.3.5 India Market Circular RNA Synthesis Service Forecast
10.3.6 Australia Market Circular RNA Synthesis Service Forecast
10.4 Europe Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.4.1 Germany Market Circular RNA Synthesis Service Forecast
10.4.2 France Market Circular RNA Synthesis Service Forecast
10.4.3 UK Market Circular RNA Synthesis Service Forecast
10.4.4 Italy Market Circular RNA Synthesis Service Forecast
10.4.5 Russia Market Circular RNA Synthesis Service Forecast
10.5 Middle East & Africa Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Circular RNA Synthesis Service Forecast
10.5.2 South Africa Market Circular RNA Synthesis Service Forecast
10.5.3 Israel Market Circular RNA Synthesis Service Forecast
10.5.4 Turkey Market Circular RNA Synthesis Service Forecast
10.6 Global Circular RNA Synthesis Service Forecast by Type (2027-2032)
10.7 Global Circular RNA Synthesis Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Circular RNA Synthesis Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Information
11.1.2 GenScript Biotech Corporation Circular RNA Synthesis Service Product Offered
11.1.3 GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GenScript Biotech Corporation Main Business Overview
11.1.5 GenScript Biotech Corporation Latest Developments
11.2 VectorBuilder
11.2.1 VectorBuilder Company Information
11.2.2 VectorBuilder Circular RNA Synthesis Service Product Offered
11.2.3 VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 VectorBuilder Main Business Overview
11.2.5 VectorBuilder Latest Developments
11.3 Guangzhou Geneseed Biotech
11.3.1 Guangzhou Geneseed Biotech Company Information
11.3.2 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product Offered
11.3.3 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Guangzhou Geneseed Biotech Main Business Overview
11.3.5 Guangzhou Geneseed Biotech Latest Developments
11.4 uBriGene Biosciences
11.4.1 uBriGene Biosciences Company Information
11.4.2 uBriGene Biosciences Circular RNA Synthesis Service Product Offered
11.4.3 uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 uBriGene Biosciences Main Business Overview
11.4.5 uBriGene Biosciences Latest Developments
11.5 Yaohai Bio-Pharma
11.5.1 Yaohai Bio-Pharma Company Information
11.5.2 Yaohai Bio-Pharma Circular RNA Synthesis Service Product Offered
11.5.3 Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Yaohai Bio-Pharma Main Business Overview
11.5.5 Yaohai Bio-Pharma Latest Developments
11.6 Creative Biogene
11.6.1 Creative Biogene Company Information
11.6.2 Creative Biogene Circular RNA Synthesis Service Product Offered
11.6.3 Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biogene Main Business Overview
11.6.5 Creative Biogene Latest Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Information
11.7.2 Creative Biolabs Circular RNA Synthesis Service Product Offered
11.7.3 Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Creative Biolabs Main Business Overview
11.7.5 Creative Biolabs Latest Developments
11.8 BOC Sciences
11.8.1 BOC Sciences Company Information
11.8.2 BOC Sciences Circular RNA Synthesis Service Product Offered
11.8.3 BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BOC Sciences Main Business Overview
11.8.5 BOC Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circular RNA Synthesis Service Market Size (2021-2032)
2.1.2 Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Circular RNA Synthesis Service by Country/Region (2021, 2025 & 2032)
2.2 Circular RNA Synthesis Service Segment by Type
2.2.1 Custom Synthesis
2.2.2 Process Development
2.2.3 Analytical and QC Services
2.2.4 Other
2.2.5 Circular RNA Synthesis Service Market Size by Type
2.2.5.1 Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
2.3 Circular RNA Synthesis Service Segment by Circularization Method
2.3.1 PIE Circularization
2.3.2 Enzymatic Ligation
2.3.3 Other
2.3.4 Circular RNA Synthesis Service Market Size by Circularization Method
2.3.4.1 Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
2.4 Circular RNA Synthesis Service Segment by Product Format
2.4.1 Naked circRNA
2.4.2 circRNA-LNP
2.4.3 Other
2.4.4 Circular RNA Synthesis Service Market Size by Product Format
2.4.4.1 Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032)
2.4.4.2 Global Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
2.5 Circular RNA Synthesis Service Segment by Application
2.5.1 Pharmaceutical and Biotechnology Companies
2.5.2 CRO and CDMO Companies
2.5.3 Other
2.5.4 Circular RNA Synthesis Service Market Size by Application
2.5.4.1 Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
3 CIRCULAR RNA SYNTHESIS SERVICE MARKET SIZE BY PLAYER
3.1 Circular RNA Synthesis Service Market Size Market Share by Player
3.1.1 Global Circular RNA Synthesis Service Revenue by Player (2021-2026)
3.1.2 Global Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
3.2 Global Circular RNA Synthesis Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULAR RNA SYNTHESIS SERVICE BY REGION
4.1 Circular RNA Synthesis Service Market Size by Region (2021-2026)
4.2 Global Circular RNA Synthesis Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.4 APAC Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.5 Europe Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Circular RNA Synthesis Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Circular RNA Synthesis Service Market Size by Country (2021-2026)
5.2 Americas Circular RNA Synthesis Service Market Size by Type (2021-2026)
5.3 Americas Circular RNA Synthesis Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circular RNA Synthesis Service Market Size by Region (2021-2026)
6.2 APAC Circular RNA Synthesis Service Market Size by Type (2021-2026)
6.3 APAC Circular RNA Synthesis Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circular RNA Synthesis Service Market Size by Country (2021-2026)
7.2 Europe Circular RNA Synthesis Service Market Size by Type (2021-2026)
7.3 Europe Circular RNA Synthesis Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circular RNA Synthesis Service by Region (2021-2026)
8.2 Middle East & Africa Circular RNA Synthesis Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Circular RNA Synthesis Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULAR RNA SYNTHESIS SERVICE MARKET FORECAST
10.1 Global Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.1 Global Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.2 Americas Circular RNA Synthesis Service Forecast
10.1.3 APAC Circular RNA Synthesis Service Forecast
10.1.4 Europe Circular RNA Synthesis Service Forecast
10.1.5 Middle East & Africa Circular RNA Synthesis Service Forecast
10.2 Americas Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.2.1 United States Market Circular RNA Synthesis Service Forecast
10.2.2 Canada Market Circular RNA Synthesis Service Forecast
10.2.3 Mexico Market Circular RNA Synthesis Service Forecast
10.2.4 Brazil Market Circular RNA Synthesis Service Forecast
10.3 APAC Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.3.1 China Circular RNA Synthesis Service Market Forecast
10.3.2 Japan Market Circular RNA Synthesis Service Forecast
10.3.3 Korea Market Circular RNA Synthesis Service Forecast
10.3.4 Southeast Asia Market Circular RNA Synthesis Service Forecast
10.3.5 India Market Circular RNA Synthesis Service Forecast
10.3.6 Australia Market Circular RNA Synthesis Service Forecast
10.4 Europe Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.4.1 Germany Market Circular RNA Synthesis Service Forecast
10.4.2 France Market Circular RNA Synthesis Service Forecast
10.4.3 UK Market Circular RNA Synthesis Service Forecast
10.4.4 Italy Market Circular RNA Synthesis Service Forecast
10.4.5 Russia Market Circular RNA Synthesis Service Forecast
10.5 Middle East & Africa Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Circular RNA Synthesis Service Forecast
10.5.2 South Africa Market Circular RNA Synthesis Service Forecast
10.5.3 Israel Market Circular RNA Synthesis Service Forecast
10.5.4 Turkey Market Circular RNA Synthesis Service Forecast
10.6 Global Circular RNA Synthesis Service Forecast by Type (2027-2032)
10.7 Global Circular RNA Synthesis Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Circular RNA Synthesis Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Information
11.1.2 GenScript Biotech Corporation Circular RNA Synthesis Service Product Offered
11.1.3 GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GenScript Biotech Corporation Main Business Overview
11.1.5 GenScript Biotech Corporation Latest Developments
11.2 VectorBuilder
11.2.1 VectorBuilder Company Information
11.2.2 VectorBuilder Circular RNA Synthesis Service Product Offered
11.2.3 VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 VectorBuilder Main Business Overview
11.2.5 VectorBuilder Latest Developments
11.3 Guangzhou Geneseed Biotech
11.3.1 Guangzhou Geneseed Biotech Company Information
11.3.2 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product Offered
11.3.3 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Guangzhou Geneseed Biotech Main Business Overview
11.3.5 Guangzhou Geneseed Biotech Latest Developments
11.4 uBriGene Biosciences
11.4.1 uBriGene Biosciences Company Information
11.4.2 uBriGene Biosciences Circular RNA Synthesis Service Product Offered
11.4.3 uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 uBriGene Biosciences Main Business Overview
11.4.5 uBriGene Biosciences Latest Developments
11.5 Yaohai Bio-Pharma
11.5.1 Yaohai Bio-Pharma Company Information
11.5.2 Yaohai Bio-Pharma Circular RNA Synthesis Service Product Offered
11.5.3 Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Yaohai Bio-Pharma Main Business Overview
11.5.5 Yaohai Bio-Pharma Latest Developments
11.6 Creative Biogene
11.6.1 Creative Biogene Company Information
11.6.2 Creative Biogene Circular RNA Synthesis Service Product Offered
11.6.3 Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biogene Main Business Overview
11.6.5 Creative Biogene Latest Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Information
11.7.2 Creative Biolabs Circular RNA Synthesis Service Product Offered
11.7.3 Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Creative Biolabs Main Business Overview
11.7.5 Creative Biolabs Latest Developments
11.8 BOC Sciences
11.8.1 BOC Sciences Company Information
11.8.2 BOC Sciences Circular RNA Synthesis Service Product Offered
11.8.3 BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BOC Sciences Main Business Overview
11.8.5 BOC Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Circular RNA Synthesis Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Custom Synthesis
Table 4. Major Players of Process Development
Table 5. Major Players of Analytical and QC Services
Table 6. Major Players of Other
Table 7. Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 10. Major Players of PIE Circularization
Table 11. Major Players of Enzymatic Ligation
Table 12. Major Players of Other
Table 13. Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Circular RNA Synthesis Service Market Size by Circularization Method (2021-2026) & ($ millions)
Table 15. Global Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
Table 16. Major Players of Naked circRNA
Table 17. Major Players of circRNA-LNP
Table 18. Major Players of Other
Table 19. Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Circular RNA Synthesis Service Market Size by Product Format (2021-2026) & ($ millions)
Table 21. Global Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
Table 22. Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 25. Global Circular RNA Synthesis Service Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
Table 27. Circular RNA Synthesis Service Key Players Head office and Products Offered
Table 28. Circular RNA Synthesis Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 33. Global Circular RNA Synthesis Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Circular RNA Synthesis Service Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 37. Americas Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 39. Americas Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 41. APAC Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 43. APAC Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 47. Europe Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Circular RNA Synthesis Service
Table 53. Key Market Challenges & Risks of Circular RNA Synthesis Service
Table 54. Key Industry Trends of Circular RNA Synthesis Service
Table 55. Global Circular RNA Synthesis Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Circular RNA Synthesis Service Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Circular RNA Synthesis Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Circular RNA Synthesis Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. GenScript Biotech Corporation Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 60. GenScript Biotech Corporation Circular RNA Synthesis Service Product Offered
Table 61. GenScript Biotech Corporation Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. GenScript Biotech Corporation Main Business
Table 63. GenScript Biotech Corporation Latest Developments
Table 64. VectorBuilder Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 65. VectorBuilder Circular RNA Synthesis Service Product Offered
Table 66. VectorBuilder Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. VectorBuilder Main Business
Table 68. VectorBuilder Latest Developments
Table 69. Guangzhou Geneseed Biotech Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 70. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product Offered
Table 71. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Guangzhou Geneseed Biotech Main Business
Table 73. Guangzhou Geneseed Biotech Latest Developments
Table 74. uBriGene Biosciences Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 75. uBriGene Biosciences Circular RNA Synthesis Service Product Offered
Table 76. uBriGene Biosciences Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. uBriGene Biosciences Main Business
Table 78. uBriGene Biosciences Latest Developments
Table 79. Yaohai Bio-Pharma Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 80. Yaohai Bio-Pharma Circular RNA Synthesis Service Product Offered
Table 81. Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Yaohai Bio-Pharma Main Business
Table 83. Yaohai Bio-Pharma Latest Developments
Table 84. Creative Biogene Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 85. Creative Biogene Circular RNA Synthesis Service Product Offered
Table 86. Creative Biogene Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Creative Biogene Main Business
Table 88. Creative Biogene Latest Developments
Table 89. Creative Biolabs Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 90. Creative Biolabs Circular RNA Synthesis Service Product Offered
Table 91. Creative Biolabs Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Creative Biolabs Main Business
Table 93. Creative Biolabs Latest Developments
Table 94. BOC Sciences Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 95. BOC Sciences Circular RNA Synthesis Service Product Offered
Table 96. BOC Sciences Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. BOC Sciences Main Business
Table 98. BOC Sciences Latest Developments
Table 1. Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Circular RNA Synthesis Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Custom Synthesis
Table 4. Major Players of Process Development
Table 5. Major Players of Analytical and QC Services
Table 6. Major Players of Other
Table 7. Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 10. Major Players of PIE Circularization
Table 11. Major Players of Enzymatic Ligation
Table 12. Major Players of Other
Table 13. Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Circular RNA Synthesis Service Market Size by Circularization Method (2021-2026) & ($ millions)
Table 15. Global Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
Table 16. Major Players of Naked circRNA
Table 17. Major Players of circRNA-LNP
Table 18. Major Players of Other
Table 19. Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Circular RNA Synthesis Service Market Size by Product Format (2021-2026) & ($ millions)
Table 21. Global Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
Table 22. Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 25. Global Circular RNA Synthesis Service Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
Table 27. Circular RNA Synthesis Service Key Players Head office and Products Offered
Table 28. Circular RNA Synthesis Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 33. Global Circular RNA Synthesis Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Circular RNA Synthesis Service Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 37. Americas Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 39. Americas Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 41. APAC Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 43. APAC Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 47. Europe Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Circular RNA Synthesis Service
Table 53. Key Market Challenges & Risks of Circular RNA Synthesis Service
Table 54. Key Industry Trends of Circular RNA Synthesis Service
Table 55. Global Circular RNA Synthesis Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Circular RNA Synthesis Service Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Circular RNA Synthesis Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Circular RNA Synthesis Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. GenScript Biotech Corporation Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 60. GenScript Biotech Corporation Circular RNA Synthesis Service Product Offered
Table 61. GenScript Biotech Corporation Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. GenScript Biotech Corporation Main Business
Table 63. GenScript Biotech Corporation Latest Developments
Table 64. VectorBuilder Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 65. VectorBuilder Circular RNA Synthesis Service Product Offered
Table 66. VectorBuilder Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. VectorBuilder Main Business
Table 68. VectorBuilder Latest Developments
Table 69. Guangzhou Geneseed Biotech Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 70. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product Offered
Table 71. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Guangzhou Geneseed Biotech Main Business
Table 73. Guangzhou Geneseed Biotech Latest Developments
Table 74. uBriGene Biosciences Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 75. uBriGene Biosciences Circular RNA Synthesis Service Product Offered
Table 76. uBriGene Biosciences Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. uBriGene Biosciences Main Business
Table 78. uBriGene Biosciences Latest Developments
Table 79. Yaohai Bio-Pharma Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 80. Yaohai Bio-Pharma Circular RNA Synthesis Service Product Offered
Table 81. Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Yaohai Bio-Pharma Main Business
Table 83. Yaohai Bio-Pharma Latest Developments
Table 84. Creative Biogene Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 85. Creative Biogene Circular RNA Synthesis Service Product Offered
Table 86. Creative Biogene Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Creative Biogene Main Business
Table 88. Creative Biogene Latest Developments
Table 89. Creative Biolabs Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 90. Creative Biolabs Circular RNA Synthesis Service Product Offered
Table 91. Creative Biolabs Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Creative Biolabs Main Business
Table 93. Creative Biolabs Latest Developments
Table 94. BOC Sciences Details, Company Type, Circular RNA Synthesis Service Area Served and Its Competitors
Table 95. BOC Sciences Circular RNA Synthesis Service Product Offered
Table 96. BOC Sciences Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. BOC Sciences Main Business
Table 98. BOC Sciences Latest Developments
LIST OF FIGURES
Figure 1. Circular RNA Synthesis Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circular RNA Synthesis Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Circular RNA Synthesis Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Circular RNA Synthesis Service Sales Market Share by Country/Region (2025)
Figure 8. Circular RNA Synthesis Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Circular RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 10. Global Circular RNA Synthesis Service Market Size Market Share by Circularization Method in 2025
Figure 11. Global Circular RNA Synthesis Service Market Size Market Share by Product Format in 2025
Figure 12. Circular RNA Synthesis Service in Pharmaceutical and Biotechnology Companies
Figure 13. Global Circular RNA Synthesis Service Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Circular RNA Synthesis Service in CRO and CDMO Companies
Figure 15. Global Circular RNA Synthesis Service Market: CRO and CDMO Companies (2021-2026) & ($ millions)
Figure 16. Circular RNA Synthesis Service in Other
Figure 17. Global Circular RNA Synthesis Service Market: Other (2021-2026) & ($ millions)
Figure 18. Global Circular RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 19. Global Circular RNA Synthesis Service Revenue Market Share by Player in 2025
Figure 20. Global Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 21. Americas Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 22. APAC Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 23. Europe Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 25. Americas Circular RNA Synthesis Service Value Market Share by Country in 2025
Figure 26. United States Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Circular RNA Synthesis Service Market Size Market Share by Region in 2025
Figure 31. APAC Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 32. APAC Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 33. China Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 37. India Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Circular RNA Synthesis Service Market Size Market Share by Country in 2025
Figure 40. Europe Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 41. Europe Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 42. Germany Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 43. France Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 56. APAC Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 57. Europe Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 59. United States Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 60. Canada Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 61. Mexico Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 62. Brazil Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 63. China Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 64. Japan Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 65. Korea Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 67. India Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 68. Australia Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 69. Germany Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 70. France Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 71. UK Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 72. Italy Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 73. Russia Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 74. Egypt Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 75. South Africa Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 76. Israel Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 77. Turkey Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 78. Global Circular RNA Synthesis Service Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Circular RNA Synthesis Service Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 1. Circular RNA Synthesis Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circular RNA Synthesis Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Circular RNA Synthesis Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Circular RNA Synthesis Service Sales Market Share by Country/Region (2025)
Figure 8. Circular RNA Synthesis Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Circular RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 10. Global Circular RNA Synthesis Service Market Size Market Share by Circularization Method in 2025
Figure 11. Global Circular RNA Synthesis Service Market Size Market Share by Product Format in 2025
Figure 12. Circular RNA Synthesis Service in Pharmaceutical and Biotechnology Companies
Figure 13. Global Circular RNA Synthesis Service Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Circular RNA Synthesis Service in CRO and CDMO Companies
Figure 15. Global Circular RNA Synthesis Service Market: CRO and CDMO Companies (2021-2026) & ($ millions)
Figure 16. Circular RNA Synthesis Service in Other
Figure 17. Global Circular RNA Synthesis Service Market: Other (2021-2026) & ($ millions)
Figure 18. Global Circular RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 19. Global Circular RNA Synthesis Service Revenue Market Share by Player in 2025
Figure 20. Global Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 21. Americas Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 22. APAC Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 23. Europe Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 25. Americas Circular RNA Synthesis Service Value Market Share by Country in 2025
Figure 26. United States Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Circular RNA Synthesis Service Market Size Market Share by Region in 2025
Figure 31. APAC Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 32. APAC Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 33. China Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 37. India Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Circular RNA Synthesis Service Market Size Market Share by Country in 2025
Figure 40. Europe Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 41. Europe Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 42. Germany Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 43. France Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 56. APAC Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 57. Europe Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 59. United States Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 60. Canada Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 61. Mexico Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 62. Brazil Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 63. China Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 64. Japan Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 65. Korea Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 67. India Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 68. Australia Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 69. Germany Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 70. France Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 71. UK Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 72. Italy Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 73. Russia Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 74. Egypt Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 75. South Africa Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 76. Israel Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 77. Turkey Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 78. Global Circular RNA Synthesis Service Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Circular RNA Synthesis Service Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
